Obstetrics and Gynecology

1046 questions

Question 181Question →

An otherwise healthy couple arrives at the reproductive endocrinology clinic for their first consultation regarding primary infertility. They have been actively attempting to conceive for 18 months without success. The female partner is 27 years old, reports predictable 28-day menstrual cycles, and denies any history of pelvic pain, abdominal surgeries, or sexually transmitted infections. The male partner is 29 years old and has no significant past medical history. They are eager to understand the step-by-step process of their care. Arrange the following steps of their evaluation and management in the most appropriate standard chronological sequence, starting from the initial diagnostic step and concluding with the most advanced therapeutic intervention.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for a standard infertility protocol is: 1) Perform a semen analysis, 2) Assess fallopian tube patency via HSG, 3) Conduct a trial of controlled ovarian stimulation with IUI, and 4) Proceed to IVF.
The standard infertility evaluation follows a logical progression from non-invasive diagnostic tests to more invasive diagnostics, followed by conservative treatments, and finally advanced reproductive technologies. Semen analysis identifies male factors non-invasively; HSG identifies anatomical barriers; IUI serves as the initial low-risk treatment for unexplained infertility; and IVF serves as the definitive treatment for refractory cases.

Step-by-Step Solution

1
Perform a semen analysis of the male partner.
Evaluates for male factor infertility.
Male factor infertility accounts for nearly 40-50% of cases. Semen analysis is a non-invasive, inexpensive initial test that must be performed before subjecting the female partner to more invasive diagnostic procedures.
2
Assess fallopian tube patency via hysterosalpingography (HSG).
Evaluates for tubal factor infertility.
Because the female patient has regular 28-day cycles (suggesting normal ovulation), the next diagnostic step is to ensure there are no structural blockages in the fallopian tubes. Patent tubes are an absolute requirement for natural conception or IUI.
3
Conduct a trial of controlled ovarian stimulation with intrauterine insemination (IUI).
Serves as the initial therapeutic intervention.
If all initial diagnostic tests (semen analysis, ovulation assessment, HSG) are normal, the couple has 'unexplained infertility.' The standard first-line treatment is typically 3 to 4 cycles of ovulation induction paired with IUI, which is less invasive and less costly than advanced therapies.
4
Proceed to in vitro fertilization (IVF).
Provides definitive, advanced assisted reproduction.
IVF is indicated when first-line therapies (like IUI) have failed, or if severe irreversible factors (such as bilateral tubal occlusion or severe male oligospermia) are discovered during the initial diagnostic workup.

Key Concept

Stepwise evaluation and management of primary infertility
Estimated Time:1m 0s
Question 182Question →

Match each obstetric clinical scenario to the most appropriate targeted pharmacologic intervention, taking into account the specific indications and contraindications for each patient.

Click a left item, then click its matching right item

Items

Postpartum hemorrhage due to uterine atony in a normotensive patient with a history of severe persistent asthma; initial oxytocin therapy has failed.
Postpartum hemorrhage due to uterine atony in a patient with preeclampsia and a current blood pressure of 165/110165/110 mmHg; initial oxytocin therapy has failed.
New-onset generalized tonic-clonic seizures in a patient at 3737 weeks gestation with severe headache, proteinuria, and a blood pressure of 180/115180/115 mmHg.
Preterm labor at 3131 weeks gestation in a patient with a documented history of myasthenia gravis requiring tocolytic therapy.

Matches

Show answer & explanation

Answer

The scenarios match to their respective interventions based on critical contraindications: the asthmatic patient receives methylergonovine, the hypertensive patient receives carboprost tromethamine, the eclamptic patient receives magnesium sulfate, and the myasthenia gravis patient receives nifedipine.
Correct matching relies on pairing the clinical presentation with the drug that avoids the patient's absolute contraindications while effectively treating the underlying obstetric emergency.

Step-by-Step Solution

1
Evaluate the first scenario involving postpartum hemorrhage in an asthmatic patient.
Identify that carboprost tromethamine is contraindicated due to its bronchoconstrictive effects. Select methylergonovine as the safe alternative.
Carboprost is a prostaglandin F2-alpha analogue that stimulates smooth muscle, including bronchial smooth muscle.
2
Evaluate the second scenario involving postpartum hemorrhage in a patient with severe hypertension.
Identify that methylergonovine is contraindicated as it can cause profound vasoconstriction and hypertensive crisis. Select carboprost tromethamine.
Methylergonovine is an ergot alkaloid that can lead to stroke or myocardial infarction in hypertensive patients.
3
Evaluate the third scenario involving a pregnant patient presenting with new-onset seizures and severe hypertension.
Diagnose eclampsia and select magnesium sulfate as the appropriate intervention.
Magnesium sulfate raises the seizure threshold and is the standard of care for eclamptic seizure termination and prophylaxis.
4
Evaluate the fourth scenario involving preterm labor in a patient with myasthenia gravis.
Recognize that magnesium sulfate is contraindicated and select the calcium channel blocker nifedipine for tocolysis.
Magnesium competitively inhibits calcium channels at the presynaptic motor nerve terminal, reducing acetylcholine release and exacerbating myasthenic weakness.

Key Concept

Pharmacological management of acute obstetric complications requires precise selection of uterotonics, anticonvulsants, and tocolytics by identifying strict maternal contraindications (e.g., asthma, hypertension, myasthenia gravis).
Question 183Question →

An established 3737-year-old patient visits the outpatient clinic requesting a new birth control strategy. Over the last 99 months, she has experienced increasingly heavy menstrual bleeding, often soaking through her clothes and requiring her to take days off work. She previously relied on condoms but desires a highly effective, long-acting method. Her medical background is significant for recurrent right-sided headaches that are preceded by visual bright spots, for which she occasionally takes sumatriptan. She currently consumes one pack of cigarettes per day. Vital signs include a blood pressure of 122/78122/78 mm Hg, a heart rate of 7676/min, and a body mass index (BMI) of 2323 kg/m 2^2. General physical and pelvic examinations are unremarkable. A urine human chorionic gonadotropin test is negative.

Laboratory studies reveal:
Hemoglobin: 10.510.5 g/dL
Thyroid-stimulating hormone: 2.12.1 mIU/L
Prolactin: 1414 ng/mL

The patient firmly declines any permanent surgical interventions. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Insert a levonorgestrel-eluting intrauterine system

Answer

The most appropriate next step is to insert a levonorgestrel-eluting intrauterine system, as it provides safe contraception without estrogen and effectively treats heavy menstrual bleeding.
The correct management is the insertion of a levonorgestrel-eluting intrauterine system (LNG-IUS). This patient requires highly effective contraception but possesses two absolute contraindications (WHO MEC category 4) to estrogen-containing methods: a history of migraine with aura (high ischemic stroke risk) and being a smoker aged 35 or older (high myocardial infarction and venous thromboembolism risk). Thus, combined oral pills, patches, and vaginal rings are strictly contraindicated. She also requires treatment for heavy menstrual bleeding. The LNG-IUS is a progestin-only method that is safe for her risk profile (MEC category 1 and 2). It releases levonorgestrel locally, which profoundly thins the endometrial lining, making it an excellent first-line medical therapy for heavy menstrual bleeding.

Step-by-Step Solution

1
Evaluate the patient's medical history for contraceptive contraindications using WHO Medical Eligibility Criteria.
The patient has migraine with aura and is a smoker over the age of 3535.
Both of these conditions are WHO MEC category 4 (absolute contraindications) for any combined hormonal contraceptives (CHCs) due to an unacceptably high risk of ischemic stroke and myocardial infarction.
2
Analyze the nature of the patient's primary gynecologic complaint.
The patient suffers from heavy menstrual bleeding resulting in mild anemia (Hemoglobin 10.510.5 g/dL).
Identifying the bleeding pattern is crucial because certain non-hormonal methods, specifically the copper intrauterine device, can exacerbate endometrial blood loss.
3
Determine if structural or malignant evaluation is immediately required.
Endometrial biopsy is deferred.
The patient is under 4545 years old, has a normal BMI (2323 kg/m 2^2), and lacks risk factors for unopposed estrogen exposure (like PCOS), making an endometrial biopsy unnecessary prior to initiating medical management.
4
Select the optimal therapeutic method that addresses both family planning and symptom management.
The levonorgestrel-eluting intrauterine system (LNG-IUS) is selected.
The LNG-IUS provides highly effective, long-acting contraception, is estrogen-free (safe for her cardiovascular risk profile), and acts locally to thin the endometrium, directly treating her heavy menstrual bleeding.

Key Concept

WHO Medical Eligibility Criteria (MEC) for contraception and the dual management of family planning and heavy menstrual bleeding in high-risk cardiovascular patients.
Estimated Time:1m 30s
Question 184Question →

A 19-year-old collegiate gymnast comes to the clinic for evaluation of absent menstrual periods for the past 10 months. Menarche occurred at age 13, and her menses were previously regular, occurring every 28 to 30 days. She trains approximately 25 hours per week and follows a strict, calorie-restricted diet to maintain her competition weight. Four weeks ago, she sustained a tibial stress fracture. She does not use tobacco, alcohol, or illicit drugs. She is not sexually active. Vital signs show a blood pressure of 94/60 mm Hg and a heart rate of 52/min. Her BMI is 17.8 kg/m217.8 \text{ kg/m}^2. Physical examination is unremarkable except for fine, downy hair over her face and arms. Pelvic examination reveals normal female external genitalia and a normal appearing cervix.

Laboratory studies show:

TestResult
β\beta-hCG, serumNegative
Follicle-stimulating hormone2.1 mIU/mL2.1 \text{ mIU/mL}
Luteinizing hormone0.8 mIU/mL0.8 \text{ mIU/mL}
Prolactin8 ng/mL8 \text{ ng/mL}
Thyroid-stimulating hormone1.4 μU/mL1.4 \text{ }\mu\text{U/mL}
Estradiol15 pg/mL15 \text{ pg/mL}

A dual-energy x-ray absorptiometry (DEXA) scan reveals a Z-score of −2.2-2.2 at the lumbar spine. The patient is anxious about her bone health and requests a prescription to "fix her hormones." She states she must maintain her current training intensity for an upcoming championship. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Multidisciplinary intervention focusing on increased caloric intake and modified exercise

Answer

The correct approach is a multidisciplinary intervention focusing on increased caloric intake and modified exercise.
This patient presents with classic signs of functional hypothalamic amenorrhea (FHA) due to relative energy deficiency in sport, part of the female athlete triad (low energy availability, menstrual dysfunction, and low bone mineral density). Her extreme exercise and caloric restriction suppress the hypothalamic-pituitary-ovarian axis, resulting in low GnRH pulsatility and subsequently low FSH, LH, and estradiol levels. The primary and most effective initial treatment for FHA is a multidisciplinary approach involving a physician, dietitian, and mental health professional to increase caloric intake and optimize energy availability. This restores normal hypothalamic function, leading to the resumption of spontaneous menses and improvement in bone mineral density.

Step-by-Step Solution

1
Interpret the clinical presentation and laboratory findings.
The patient has a low BMI, an intense exercise regimen, secondary amenorrhea, and low gonadotropins with low estradiol. This is classic for functional hypothalamic amenorrhea (FHA) secondary to relative energy deficiency in sport (the female athlete triad).
Establishing the etiology of the secondary amenorrhea is necessary to guide appropriate therapy.
2
Evaluate the patient's bone health status.
The DEXA scan shows a Z-score of -2.2, confirming low bone mineral density (osteopenia/osteoporosis) secondary to prolonged hypoestrogenism, complicated by a recent stress fracture.
Determining the severity of complications from FHA informs the urgency and modality of treatment.
3
Select the most appropriate initial management for FHA.
The primary, most effective treatment is reversing the energy deficit through multidisciplinary nutritional and psychological intervention.
Restoring energy availability naturally reactivates the hypothalamic-pituitary-ovarian axis, which is superior to pharmacologic therapy for restoring both menses and bone mineral density.

Key Concept

The initial management of functional hypothalamic amenorrhea (female athlete triad) is a multidisciplinary approach to increase energy availability. Combined oral contraceptives are contraindicated for bone protection because oral estrogen suppresses hepatic IGF-1, a critical hormone for bone formation.
Estimated Time:1m 30s
Question 185Question →

Match each classic clinical finding in a patient with primary postpartum hemorrhage to its most likely underlying etiology.

Click a left item, then click its matching right item

Items

Soft, enlarged uterus palpable above the umbilicus with heavy vaginal bleeding
Firm, well-contracted uterus with a persistent trickle of bright red vaginal blood
Absence of a cotyledon on visual inspection of the delivered placenta
Generalized oozing from intravenous catheter sites and mucosal surfaces

Matches

Show answer & explanation

Answer

Soft, enlarged uterus matches with Uterine atony. Firm, well-contracted uterus with steady bleeding matches with Genital tract laceration. Absence of a cotyledon matches with Retained placental tissue. Generalized oozing matches with Coagulopathy.
Primary postpartum hemorrhage is most commonly caused by uterine atony, which presents with a boggy uterus. If the uterus is firm but bleeding persists, a genital tract laceration is highly likely. Retained placental tissue is diagnosed when parts of the placenta are visibly missing upon inspection, and systemic oozing points toward a consumptive coagulopathy.

Step-by-Step Solution

1
Evaluate the clinical finding of a soft, enlarged uterus with heavy bleeding.
This identifies an impairment in myometrial contraction.
Uterine atony (Tone) is the most common cause of postpartum hemorrhage and classically presents with a 'boggy' uterus.
2
Evaluate the finding of a firm uterus with continuous bleeding.
This identifies a structural injury rather than a contraction issue.
Genital tract lacerations (Trauma) bleed persistently even when the uterus is well-contracted.
3
Evaluate the finding of a missing cotyledon on the placenta.
This identifies incomplete delivery of the placenta.
Retained placental tissue (Tissue) prevents the uterus from contracting fully, causing hemorrhage.
4
Evaluate the finding of oozing from IV sites.
This identifies a systemic hemostatic failure.
Coagulopathy (Thrombin) causes systemic bleeding, distinguishing it from localized obstetric causes of hemorrhage.

Key Concept

The etiologies of primary postpartum hemorrhage are classically categorized by the '4 Ts': Tone (uterine atony), Trauma (genital tract lacerations), Tissue (retained placenta), and Thrombin (coagulopathy).
Question 186Question →

A 25-year-old woman is evaluated in the emergency department for severe bilateral lower quadrant abdominal pain, intractable nausea, and a fever of 39.1∘C39.1^{\circ}\text{C} (102.4∘F102.4^{\circ}\text{F}). She is unable to tolerate oral fluids. On pelvic examination, there is severe cervical motion tenderness and a palpable left adnexal fullness. Arrange the following steps in the correct chronological sequence for the standard diagnostic workup and management escalation of this patient's suspected complicated Pelvic Inflammatory Disease (PID).

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is to first obtain a pregnancy test, followed by a pelvic ultrasound, then admit the patient for intravenous antibiotics, and finally proceed with surgical drainage if she fails to improve.
The correct management of complicated Pelvic Inflammatory Disease (PID) follows a logical escalation from vital non-invasive diagnostics to medical therapy, and finally to invasive procedures. In any woman of childbearing age presenting with lower abdominal pain, a pregnancy test is the absolute first step to rule out ectopic pregnancy. Once ruled out, the palpable adnexal mass requires evaluation with pelvic ultrasonography to assess for a tubo-ovarian abscess (TOA). Because this patient exhibits systemic toxicity (high fever), an inability to tolerate oral fluids, and a possible TOA, she meets strict criteria for inpatient management with broad-spectrum intravenous antibiotics (e.g., cefoxitin and doxycycline). Invasive treatments, such as image-guided or surgical drainage, are reserved as a last resort for patients who fail to show clinical improvement after 48 to 72 hours of intravenous antibiotic therapy.

Step-by-Step Solution

1
Rule out ectopic pregnancy
Serum β\beta-hCG test is performed
It is the universal first step in evaluating acute abdominal pain in females of childbearing age.
2
Evaluate the anatomical extent of the infection
Pelvic ultrasound is obtained
Imaging is required to identify a tubo-ovarian abscess (TOA) corresponding to the palpable adnexal fullness.
3
Treat the severe, complicated infection medically
Hospital admission and IV antibiotics are initiated
The patient's high fever and intractable vomiting make outpatient oral therapy unsafe and ineffective.
4
Escalate treatment for refractory cases
Surgical or interventional drainage is considered
Drainage is indicated only if medical therapy fails after an adequate 48 to 72 hour trial.

Key Concept

The standard sequence of care for complicated Pelvic Inflammatory Disease involves first ruling out pregnancy, confirming anatomical complications via imaging, initiating inpatient intravenous medical therapy, and reserving invasive drainage for refractory cases.
Question 187Question →

Following a spontaneous vaginal delivery of a 4150 g4150\text{ g} neonate, a 2828-year-old multiparous patient develops sudden, massive vaginal hemorrhage. The delivery was complicated by a prolonged second stage. During the third stage of labor, strong umbilical cord traction was applied prior to spontaneous placental separation. The patient now reports severe, agonizing lower abdominal pain and severe lightheadedness. Vital signs show a blood pressure of 76/40 mmHg76/40\text{ mmHg} and a heart rate of 142/min142/\text{min}. Pelvic examination reveals a firm, smooth, beefy-red mass completely filling the vaginal vault, with the placenta still densely attached to its surface. Abdominal palpation fails to identify a uterine fundus in the pelvis. An initial bedside attempt by the physician to manually push the mass cephalad is thwarted by a tightly contracted lower cervical ring. Massive transfusion protocol is activated. Arrange the following subsequent critical management steps in the correct chronological order.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for managing a refractory uterine inversion is to first halt any uterotonics, administer a uterine relaxant, manually replace the fundus, restart uterotonics to establish tone, and finally remove the adherent placenta.
The precise chronological protocol for a refractory uterine inversion prioritizes restoring normal anatomy before addressing the third stage of labor. Because the uterus is clamped down, all uterotonics must be stopped, and a relaxant (like nitroglycerin) must be administered. Once relaxed, the uterus is pushed back into place. Only then are uterotonics given to firm up the tissue, and finally, the placenta is removed from a now-contracted, normally positioned uterus to minimize blood loss.

Step-by-Step Solution

1
Recognize the diagnosis of uterine inversion complicated by a contracted cervical ring.
Identify that the primary mechanical barrier to repositioning is myometrial contraction.
The initial manual attempt failed, indicating that the lower uterine segment has clamped down around the inverted fundus.
2
Discontinue offending agents and administer a uterine relaxant.
The cervical ring loosens.
Pushing against a contracted ring is futile and risks tissue damage; stopping oxytocin and giving nitroglycerin relaxes the smooth muscle.
3
Perform manual replacement followed immediately by uterotonics.
Normal uterine anatomy and tone are restored.
The uterus must be held in place while uterotonics take effect to prevent it from immediately reinverting due to gravity and residual relaxation.
4
Manually extract the placenta as the final step.
The third stage of labor is safely completed with minimal blood loss.
Delaying placental removal ensures the myometrium can immediately contract around the spiral arteries once the placenta is detached.

Key Concept

Sequential management of uterine inversion requires achieving uterine relaxation for replacement, followed by restoring uterine tone, and strictly delaying placental removal until normal anatomy and firm tone are established to prevent fatal hemorrhage.
Estimated Time:2m 0s
Question 188Question →

A 25-year-old woman presents to the ambulatory care clinic with complaints of increased, yellowish vaginal discharge for the past week. She denies any pelvic pain, fever, nausea, or burning with urination. The patient is sexually active with a new male partner and reports inconsistent use of barrier contraception. Her medical history is unremarkable, and she takes only a daily oral contraceptive pill. Vital signs show a temperature of 37.1°C (98.8°F), blood pressure of 118/76 mmHg, and a heart rate of 78/min. On pelvic examination, the vagina appears normal, but the cervix is erythematous, edematous, and bleeds easily upon speculum contact. A sample of mucopurulent discharge is visible at the cervical os. Bimanual examination demonstrates a normal-sized, non-tender uterus and no adnexal masses or cervical motion tenderness. A rapid nucleic acid amplification test (NAAT) performed in the clinic on a cervical swab returns positive for *Neisseria gonorrhoeae* and negative for *Chlamydia trachomatis*.

Which of the following is the most appropriate pharmacotherapy for this patient?

Show answer & explanation

Answer: Ceftriaxone

Answer

Ceftriaxone
The patient is presenting with uncomplicated gonococcal cervicitis. Current treatment guidelines recommend treating isolated gonococcal infections with high-dose intramuscular ceftriaxone monotherapy. Historically, empiric dual therapy with azithromycin was standard to treat potential chlamydial coinfection and theoretically slow gonococcal resistance. However, due to rising macrolide resistance, azithromycin is no longer recommended in this context. Furthermore, because this patient's rapid NAAT definitively ruled out Chlamydia trachomatis, the addition of doxycycline is unnecessary. Thus, ceftriaxone alone is the most appropriate targeted therapy.

Step-by-Step Solution

1
Interpret the clinical presentation and rapid laboratory findings.
The patient has uncomplicated gonococcal cervicitis (NAAT positive for N. gonorrhoeae, negative for C. trachomatis).
Establishing a definitive microbiological diagnosis is required to select targeted therapy rather than broad empiric therapy.
2
Determine the guideline-concordant targeted antimicrobial therapy.
High-dose intramuscular ceftriaxone monotherapy is indicated.
Updated guidelines dictate that if chlamydia has been definitively ruled out, dual antibiotic therapy should be avoided to promote antimicrobial stewardship and limit macrolide resistance.

Key Concept

Targeted treatment of uncomplicated gonococcal cervicitis with ceftriaxone monotherapy when chlamydial coinfection is ruled out.
Question 189Question →

A 25-year-old primigravida at 38 weeks gestation is evaluated in the labor and delivery unit for active labor. Her pregnancy has been uncomplicated. Her temperature is 37.0°C (98.6°F), blood pressure is 118/76 mm Hg, and pulse is 82/min. Cervical examination reveals 5 cm dilation, 100% effacement, and 0 station. Artificial rupture of membranes was performed 1 hour ago, yielding clear amniotic fluid. Uterine contractions are occurring every 3 to 4 minutes and palpate as strong. External fetal monitoring shows a baseline heart rate of 140/min with moderate variability. Over the last 30 minutes, there are abrupt decreases in the fetal heart rate to 85/min that last for 40 to 50 seconds before rapidly returning to baseline. These decreases occur in association with 60% of the uterine contractions, and their timing varies relative to the peak of the contractions. The patient is currently positioned in the left lateral decubitus position and is receiving a bolus of intravenous lactated Ringer solution, but the fetal heart rate pattern remains unchanged. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Initiation of amnioinfusion

Answer

Initiation of amnioinfusion
The patient's external fetal heart rate tracing demonstrates recurrent variable decelerations. Variable decelerations are defined by an abrupt decrease in the fetal heart rate (onset to nadir < 30 seconds) and are typically caused by umbilical cord compression. They are considered recurrent when they occur with 50% or more of uterine contractions in a 20-minute window. Initial management involves intrauterine resuscitation techniques, including maternal repositioning (to physically shift the fetus off the cord) and intravenous fluid administration. Because this patient is already receiving these interventions without improvement, and her membranes are already ruptured, the next best step is the initiation of an amnioinfusion. Amnioinfusion involves the transcervical instillation of normal saline or lactated Ringer solution directly into the amniotic cavity. This procedure artificially increases the amniotic fluid volume, providing a protective cushion around the umbilical cord, thereby relieving compression and decreasing the likelihood of requiring a cesarean delivery for an abnormal FHR tracing.

Step-by-Step Solution

1
Analyze the fetal heart rate (FHR) tracing to identify the pattern.
The FHR shows abrupt decreases (<30 seconds from onset to nadir) that vary in timing with contractions, indicating variable decelerations.
Accurate interpretation of the FHR tracing is required to determine the underlying pathophysiology, which in this case is umbilical cord compression.
2
Determine the severity and frequency of the decelerations.
The variable decelerations are classified as recurrent because they occur with >50% of uterine contractions over a 30-minute period.
Recurrent variable decelerations require active intervention to prevent progressive fetal hypoxemia and acidemia.
3
Evaluate the response to initial intrauterine resuscitation.
The patient is already in the left lateral decubitus position and receiving IV fluids, but the decelerations persist.
Initial conservative measures have failed to alleviate the cord compression.
4
Select the next appropriate intervention based on standard management guidelines.
Amnioinfusion is indicated to artificially increase amniotic fluid volume and relieve umbilical cord compression.
Amnioinfusion is the next appropriate step for recurrent variable decelerations unresponsive to initial measures in a patient with ruptured membranes, before resorting to cesarean delivery.

Key Concept

Recurrent variable decelerations are typically caused by umbilical cord compression and are managed first with maternal repositioning and IV fluids, followed by amnioinfusion if initial measures fail.
Question 190Question →

A 34-year-old woman comes to the office for evaluation of secondary amenorrhea. Her last menstrual period was 14 months ago. At that time, she underwent a dilation and curettage for an incomplete abortion, which was complicated by postpartum endometritis requiring intravenous antibiotics. Prior to this pregnancy, her menstrual cycles were regular every 28 days. She reports no hot flashes, galactorrhea, weight changes, or visual disturbances. Her body mass index is 23 kg/m². Physical examination reveals normal secondary sexual characteristics and no evidence of hirsutism or acne. A urine pregnancy test is negative. Serum laboratory testing shows normal levels of follicle-stimulating hormone, luteinizing hormone, prolactin, and thyroid-stimulating hormone. A 10-day course of oral medroxyprogesterone acetate is administered, but no withdrawal bleeding occurs. Subsequently, she is given a 21-day course of oral estrogen followed by 7 days of progestin, which also fails to induce withdrawal bleeding. Which of the following is the most likely diagnosis?

Show answer & explanation

Answer: Intrauterine synechiae

Answer

Intrauterine synechiae
The correct answer is intrauterine synechiae (Asherman syndrome). This patient has secondary amenorrhea with a classic history of uterine instrumentation (dilation and curettage) complicated by endometritis. In the standard evaluation of amenorrhea, a failure to experience withdrawal bleeding after both a progestin challenge and a subsequent estrogen-progestin challenge indicates an anatomic defect of the outflow tract, such as endometrial destruction or scarring. Her normal hormone levels further rule out central and ovarian etiologies.

Step-by-Step Solution

1
Analyze the patient's presenting symptoms and medical history.
The patient has secondary amenorrhea following a dilation and curettage complicated by an intrauterine infection (endometritis).
Identifying the antecedent event is critical for suspecting an anatomic cause of secondary amenorrhea.
2
Interpret the laboratory findings.
Follicle-stimulating hormone, luteinizing hormone, prolactin, and thyroid-stimulating hormone are all within normal limits.
Normal pituitary, thyroid, and ovarian hormones rule out primary ovarian insufficiency, hypothalamic amenorrhea, and hyperprolactinemia.
3
Evaluate the response to hormonal challenge tests.
The patient fails to bleed after a progestin challenge and after subsequent sequential estrogen-progestin therapy.
Failure to bleed despite adequate exogenous estrogen and progestin confirms an unresponsive endometrium or obstructed outflow tract, diagnosing intrauterine synechiae.

Key Concept

In the workup of secondary amenorrhea, a failure to experience withdrawal bleeding after sequential exogenous estrogen and progestin administration points to an anatomic outflow tract defect, most commonly Asherman syndrome (intrauterine synechiae) when there is a history of uterine instrumentation.
Question 191Question →

A 32-year-old woman comes to the office due to the absence of menstrual periods for the past 9 months. Her menarche occurred at age 13, and her menses were previously regular, occurring every 28 days and lasting 5 days. Over the last year, she has experienced progressive fatigue, cold intolerance, and a 5-kg (11-lb) weight gain despite a decreased appetite. She has no headaches, visual disturbances, or galactorrhea. Her medical history is unremarkable, and she takes no medications. Vital signs show a blood pressure of 102/64 mmHg and a pulse of 54/min. Physical examination reveals dry, cool skin and a delayed relaxation phase of the deep tendon reflexes. Pelvic examination is normal with no clitoromegaly. A urine pregnancy test is negative.

Laboratory evaluation shows:
Thyroid-stimulating hormone (TSH): 1.3 mIU/L (Normal: 0.5–5.0 mIU/L)
Free thyroxine (T4): 0.4 ng/dL (Normal: 0.8–1.8 ng/dL)
Prolactin: 12 ng/mL (Normal: < 25 ng/mL)
Follicle-stimulating hormone (FSH): 3 mIU/mL (Normal: 5–20 mIU/mL)
Luteinizing hormone (LH): 2 mIU/mL (Normal: 5–20 mIU/mL)

Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Magnetic resonance imaging of the pituitary gland

Answer

Magnetic resonance imaging of the pituitary gland
The patient presents with secondary amenorrhea, fatigue, weight gain, and delayed deep tendon reflexes, which strongly suggest hypothyroidism. However, her laboratory results show a low free T4 level paired with an inappropriately normal TSH. In primary hypothyroidism, the intact pituitary responds to low T4 by increasing TSH production. The absence of this normal feedback response (a normal TSH despite low T4) indicates central (secondary) hypothyroidism. Furthermore, her amenorrhea is accompanied by low-normal FSH and LH levels, pointing to concurrent hypogonadotropic hypogonadism. The presence of multiple anterior pituitary hormone deficiencies (panhypopituitarism) raises high suspicion for a pituitary or hypothalamic disorder, such as a non-functioning pituitary macroadenoma. Therefore, the most appropriate next step in management is to perform magnetic resonance imaging (MRI) of the brain and pituitary gland to evaluate for a structural lesion.

Step-by-Step Solution

1
Interpret the clinical presentation and initial laboratory findings.
The patient has secondary amenorrhea, clinical signs of hypothyroidism, a low free T4, and an inappropriately normal TSH.
To differentiate between primary and secondary (central) causes of endocrine dysfunction.
2
Identify the underlying pathophysiologic process.
The combination of central hypothyroidism and hypogonadotropic hypogonadism indicates panhypopituitarism.
Multiple anterior pituitary hormone deficiencies suggest a structural lesion in the pituitary or hypothalamus.
3
Determine the most appropriate next step in management.
Magnetic resonance imaging of the pituitary gland is indicated.
To evaluate for a compressive mass, such as a non-functioning pituitary macroadenoma, causing the hypopituitarism.

Key Concept

Evaluation of secondary amenorrhea and panhypopituitarism
Question 192Question →

An obstetrical care team is evaluating a patient at 39 weeks gestation who is undergoing an induction of labor for gestational diabetes mellitus. She is currently receiving a continuous intravenous oxytocin infusion. Ten minutes ago, she reported a sudden onset of mild shortness of breath. Her vital signs are temperature 37.0∘C37.0^\circ\text{C} (98.6∘F98.6^\circ\text{F}), blood pressure 122/78 mm Hg122/78\text{ mm Hg}, heart rate 95/min95\text{/min}, and respiratory rate 20/min20\text{/min}. Oxygen saturation is 98%98\% on room air. An arterial blood gas analysis reveals:

* pH\text{pH}: 7.447.44
* PaCO2\text{PaCO}_2: 29 mm Hg29\text{ mm Hg}
* PaO2\text{PaO}_2: 104 mm Hg104\text{ mm Hg}

The electronic fetal monitor demonstrates a baseline heart rate of 145/min145\text{/min} with moderate variability. In the past 20 minutes, there have been five uterine contractions. Following three of these contractions, the fetal heart rate gradually decreased to a nadir of 125/min125\text{/min}, with the nadir occurring after the peak of the contraction, before returning to the baseline. The cervix is 5 cm dilated and 80% effaced. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Discontinue the oxytocin infusion and reposition the patient

Answer

The most appropriate next step in management is to discontinue the oxytocin infusion and reposition the patient.
The correct answer is to discontinue the oxytocin infusion and reposition the patient. The electronic fetal monitor demonstrates recurrent late decelerations (occurring with more than 50% of contractions) in the setting of moderate variability. This combination represents a Category II fetal heart rate tracing, which signals transient uteroplacental insufficiency but indicates that the fetus is not currently acidemic. The standard initial management is intrauterine resuscitation. This includes discontinuing uterotonic agents (such as oxytocin) to reduce uterine workload and repositioning the patient (typically to the left lateral decubitus position) to relieve aortocaval compression and maximize uteroplacental blood flow.

Step-by-Step Solution

1
Evaluate the maternal vital signs and arterial blood gas analysis in the context of pregnancy.
The pH of 7.44 and PaCO2 of 29 mm Hg represent a normal, compensated physiologic chronic respiratory alkalosis due to progesterone-induced hyperventilation. The mild shortness of breath is a common physiologic finding.
To rule out maternal respiratory compromise, such as a pulmonary embolism, which would require immediate separate intervention.
2
Analyze the fetal heart rate (FHR) tracing to determine its category and the underlying pathophysiology.
The tracing shows a baseline of 145/min with moderate variability and recurrent late decelerations (occurring with >50% of contractions). This is a Category II tracing indicative of transient uteroplacental insufficiency.
Accurate interpretation of the FHR tracing dictates the urgency and type of obstetric intervention.
3
Select the appropriate evidence-based intervention for a Category II tracing with recurrent late decelerations.
The correct action is intrauterine resuscitation, which includes discontinuing the oxytocin infusion and repositioning the mother to the left lateral decubitus position.
These conservative measures maximize uteroplacental blood flow and fetal oxygenation and must be attempted prior to operative delivery.

Key Concept

Management of Category II fetal heart rate tracings with recurrent late decelerations requires initial intrauterine resuscitation, while normal physiologic respiratory changes in pregnancy should not be misinterpreted as pathology.
Question 193Question →

Match each clinical presentation of a gynecologic infection with the most appropriate, guideline-concordant next step in management.

Click a left item, then click its matching right item

Items

A 27-year-old nulliparous woman with a copper intrauterine device presents with a temperature of 38.8°C (101.8°F), exquisite cervical motion tenderness, and a 6-cm complex left adnexal mass on ultrasound.
A 23-year-old pregnant woman at 8 weeks gestation complains of vulvar irritation and a malodorous, frothy, yellow-green vaginal discharge; vaginal pH is 6.5.
A 31-year-old otherwise healthy woman presents with severe vulvovaginal pruritus and thick, white, adherent discharge; this is her fifth culture-confirmed episode in the past 11 months.
A 20-year-old asymptomatic university student has a routine vaginal swab nucleic acid amplification test that returns positive for Chlamydia trachomatis and negative for Neisseria gonorrhoeae.

Matches

Show answer & explanation

Answer

The correct pairings match TOA with IV antibiotics and IUD retention, Trichomoniasis in pregnancy with a 7-day course of oral metronidazole, Recurrent VVC with fluconazole induction and 6-month maintenance, and Chlamydia with a 7-day course of oral doxycycline.
Each presentation requires a specific, guideline-based intervention: 1) TOA with an IUD requires admission and IV antibiotics without immediate IUD removal. 2) Trichomoniasis in pregnancy is treated safely with a 7-day course of metronidazole regardless of trimester. 3) Recurrent VVC (4 or more episodes annually) necessitates fluconazole induction followed by 6 months of weekly maintenance. 4) Uncomplicated chlamydia is now treated first-line with a 7-day course of oral doxycycline.

Step-by-Step Solution

1
Diagnose the specific gynecologic infection and any complicating factors presented in each vignette.
Identified Tubo-ovarian abscess (with IUD), Trichomoniasis (in 1st trimester), Recurrent VVC, and Uncomplicated Chlamydia.
Accurate diagnosis and recognition of patient context (e.g., pregnancy, IUD presence) are required to select guideline-concordant therapy.
2
Evaluate the management options focusing on updated pharmacotherapy guidelines and procedural interventions.
Recognized that IUDs do not require immediate removal in TOA, metronidazole is safe in the 1st trimester, recurrent VVC needs prolonged maintenance, and doxycycline is the updated first-line for Chlamydia.
Clinical guidelines frequently update and test understanding of antibiotic stewardship and patient safety.
3
Match the clinical presentation to the corresponding precise management step.
All 4 pairs correctly aligned.
Finalizes the cognitive process of linking presentation to best practice management.

Key Concept

Guideline-concordant management of complex and routine gynecologic infections, including nuanced considerations for pregnancy, contraceptive devices, and updated antibiotic stewardship.
Estimated Time:2m 30s
Question 194Question →

Match each severe intrapartum or puerperal complication to its most classic clinical presentation and associated risk factors.

Click a left item, then click its matching right item

Items

Uterine rupture
Amniotic fluid embolism
Uterine inversion
Vaginal hematoma
Placenta accreta spectrum

Matches

Show answer & explanation

Answer

Uterine rupture corresponds to loss of fetal station and palpable fetal parts. Amniotic fluid embolism corresponds to sudden hypoxia and DIC. Uterine inversion corresponds to a protruding vaginal mass and nonpalpable fundus. Vaginal hematoma corresponds to intense pelvic pain and a fluctuant mass with concealed hemorrhage. Placenta accreta spectrum corresponds to massive hemorrhage following attempted manual placental extraction.
Each severe obstetric complication has distinct pathophysiologic hallmarks. Uterine rupture involves complete myometrial disruption (fetal parts in abdomen). Amniotic fluid embolism is an immunologic and anaphylactoid response (hypoxia and DIC). Uterine inversion is a mechanical collapse of the uterus (vaginal mass, absent fundus). Vaginal hematomas involve paravaginal vascular injury (concealed bleeding, severe pain). Placenta accreta prevents normal placental detachment (hemorrhage on manual extraction).

Step-by-Step Solution

1
Analyze the clinical presentation of sudden hypoxia, cardiogenic shock, and DIC.
Identify this classic triad as Amniotic Fluid Embolism (AFE).
AFE is an anaphylactoid reaction to fetal antigens entering the maternal circulation, leading to rapid cardiopulmonary collapse and consumptive coagulopathy.
2
Evaluate the finding of intense pelvic pain and a fluctuant mass after an operative delivery.
Match this presentation to a Vaginal hematoma.
Operative deliveries can traumatize paravaginal vasculature. The bleeding expands into the paravaginal space, causing severe stretching of tissues (exquisite pain) while remaining externally concealed.
3
Identify the cause of massive hemorrhage upon manual extraction of a retained placenta in a patient with a prior cesarean.
Determine that this represents Placenta accreta spectrum.
Prior uterine surgery increases the risk of abnormal placental adherence. Attempting to manually shear off an abnormally adherent placenta results in profound hemorrhage.
4
Differentiate the remaining two presentations: loss of fetal station vs. a vaginal mass with a nonpalpable fundus.
Match loss of station and palpable abdominal fetal parts to Uterine rupture, and the vaginal mass with nonpalpable fundus to Uterine inversion.
In uterine rupture, the fetus extrudes into the peritoneal cavity. In uterine inversion, the uterus turns inside out, pulling the fundus down into the vagina.

Key Concept

Accurate differentiation of catastrophic intrapartum and postpartum complications based on their unique physical exam findings is critical for immediate, life-saving management.
Question 195Question →

A 2828-year-old woman, gravida 22, para 11, at 4040 weeks of gestation is evaluated on the labor unit. She was admitted 66 hours ago in spontaneous labor. Her prenatal course was unremarkable. Spontaneous rupture of membranes occurred 33 hours ago, yielding clear fluid. Her temperature is 37.1∘C37.1^\circ\text{C} (98.8∘F98.8^\circ\text{F}), blood pressure is 118/76 mm Hg118/76\text{ mm Hg}, and pulse is 82/min82/\text{min}. Vaginal examination reveals the cervix is 7 cm7\text{ cm} dilated, 100%100\% effaced, with the fetal vertex at 00 station. An external tocodynamometer records uterine contractions every 33 to 4 minutes4\text{ minutes}. The fetal heart rate tracing demonstrates a baseline of 145/min145/\text{min} with moderate variability. There are recurrent, visually abrupt decreases in the fetal heart rate to 85/min85/\text{min}. The time from the onset of the deceleration to the absolute nadir is consistently 1515 to 20 seconds20\text{ seconds}. These decelerations last approximately 50 seconds50\text{ seconds} and occur with over 80%80\% of the contractions. Notably, the nadir of each deceleration exactly matches the peak of the corresponding uterine contraction. Position changes to the left lateral decubitus and an intravenous fluid bolus fail to alter the fetal heart rate pattern. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Amnioinfusion

Answer

Amnioinfusion
The correct next step in management is amnioinfusion. This patient's fetal heart rate (FHR) tracing demonstrates recurrent variable decelerations. The critical diagnostic hallmark that distinguishes a variable deceleration from an early or late deceleration is the rate of descent. According to standard obstetric guidelines (NICHD terminology), a variable deceleration is defined by a visually abrupt decrease in the FHR, where the time from the onset of the deceleration to its nadir is <30 seconds< 30\text{ seconds}. Conversely, early and late decelerations are defined by a gradual decrease (onset to nadir ≥30 seconds\ge 30\text{ seconds}). A common pitfall is categorizing decelerations solely based on their timing relative to the uterine contraction. Although the nadir of the decelerations in this patient perfectly coincides with the peak of the contractions (a timing pattern classically taught for early decelerations), the abrupt nature of the drop (1515 to 20 seconds20\text{ seconds} to nadir) definitively categorizes them as variable decelerations. Variable decelerations are caused by umbilical cord compression. When they become recurrent (occurring with ≥50%\ge 50\% of contractions) and fail to resolve with initial conservative measures such as maternal repositioning and intravenous fluid boluses, further intervention is required to prevent fetal acidemia. Amnioinfusion involves instilling isotonic fluid into the amniotic cavity to restore fluid volume, thereby cushioning the umbilical cord and relieving the compression.

Step-by-Step Solution

1
Analyze the fetal heart rate (FHR) tracing characteristics for the rate of descent.
The FHR shows abrupt decreases, defined as the time from onset to nadir being <30 seconds< 30\text{ seconds} (specifically 1515 to 20 seconds20\text{ seconds}).
Identifying the rate of descent is the primary required criterion for classifying a deceleration as variable versus early or late.
2
Classify the deceleration type based on ACOG definitions.
The decelerations are classified as variable decelerations, regardless of the fact that their nadir aligns with the contraction peak.
Variable decelerations are defined strictly by an abrupt decrease (onset to nadir <30 seconds< 30\text{ seconds}). Early decelerations require a gradual decrease (≥30 seconds\ge 30\text{ seconds}).
3
Determine the underlying pathophysiology and severity.
The patient is experiencing recurrent variable decelerations (occurring with >50%> 50\% of contractions) due to umbilical cord compression.
The abrupt drop in FHR is a vagal response to the rapid increase in fetal blood pressure when the umbilical arteries are compressed.
4
Determine the next best step in management for recurrent variable decelerations that fail initial conservative measures.
Amnioinfusion is indicated.
Instilling normal saline into the uterine cavity artificially restores amniotic fluid, providing a fluid cushion around the umbilical cord and relieving the compression.

Key Concept

Fetal heart rate decelerations are categorized primarily by their shape (abrupt vs. gradual). An abrupt deceleration (onset to nadir <30 seconds< 30\text{ seconds}) is a variable deceleration, even if its nadir perfectly coincides with the peak of a contraction. The first-line specific treatment for recurrent variable decelerations not responding to maternal repositioning is amnioinfusion.

Alternative Method

When evaluating FHR tracings, physically counting the grid squares from the start of the FHR drop to its lowest point (nadir) can prevent errors. Each small square represents 10 seconds. If the drop takes fewer than 3 small squares (< 30 seconds), it is a variable deceleration regardless of any other features.
Estimated Time:1m 30s
Question 196Question →

A 32-year-old gravida 3, para 2 woman at 38 weeks gestation is admitted to the labor and delivery unit. She reports that her "water broke" an hour ago at home, followed immediately by a moderate amount of bright red vaginal bleeding. She denies any uterine contractions or abdominal pain. Her two previous deliveries were by cesarean section. Her blood pressure is 110/70 mm Hg, and her pulse is 88/min. The fetal heart rate tracing demonstrates a baseline of 140/min with a smooth, undulating, sine-wave-like pattern oscillating with an amplitude of 15 beats per minute at a frequency of 4 cycles per minute. There is no beat-to-beat variability, and no accelerations or decelerations are noted. The uterus is soft and non-tender on palpation. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Emergent cesarean delivery

Answer

The most appropriate next step in management is emergent cesarean delivery.
The correct answer is emergent cesarean delivery. The clinical presentation of painless vaginal bleeding immediately following spontaneous rupture of membranes, combined with a history of prior cesarean deliveries, is highly suspicious for a ruptured vasa previa. The fetal heart rate tracing described—a smooth, undulating wave with a frequency of 3-5 cycles per minute and absent beat-to-beat variability—is a sinusoidal pattern. A sinusoidal pattern is a Category III fetal heart rate tracing that specifically indicates severe fetal anemia or hypoxia. In this context, the torn fetal vessels from the vasa previa are causing rapid fetal exsanguination. Therefore, the most appropriate and life-saving next step is an emergent cesarean delivery to prevent fetal demise.

Step-by-Step Solution

1
Analyze the patient's clinical presentation.
The history of prior cesareans and painless vaginal bleeding immediately following spontaneous rupture of membranes is highly suspicious for a ruptured vasa previa.
Prior uterine surgeries increase the risk of abnormal placentation, and painless bleeding upon amniotomy is the classic presentation of torn fetal vessels.
2
Interpret the fetal heart rate tracing description.
The tracing describes a sinusoidal pattern, which is classified as a Category III tracing.
A smooth, undulating sine-wave pattern with absent beat-to-beat variability and a frequency of 3-5 cycles per minute is the hallmark of a sinusoidal tracing, indicating severe fetal anemia or hypoxia.
3
Determine the appropriate management based on the diagnosis and tracing.
Emergent cesarean delivery must be performed immediately.
A ruptured vasa previa leads to rapid fetal exsanguination (as evidenced by the sinusoidal pattern). Any delay for further diagnostics or conservative resuscitation will likely result in fetal demise.

Key Concept

A sinusoidal fetal heart rate pattern in the setting of painless vaginal bleeding after membrane rupture indicates ruptured vasa previa and severe fetal anemia, necessitating emergent cesarean delivery.
Estimated Time:1m 30s
Question 197Question →

During a routine evaluation at a women's health clinic, a 31-year-old G2P2 reports a 4-day history of worsening lower pelvic discomfort, deep dyspareunia, and intermittent vaginal spotting. Her last menstrual period occurred 2 weeks ago. She mentions becoming sexually active with a new partner two months ago. Her medical history is significant for the insertion of a copper intrauterine device three years ago. Her temperature is 38.2°C (100.8°F), blood pressure is 110/70 mmHg, and pulse is 88/min. Speculum examination reveals a yellow, mucopurulent discharge at the cervical os along with visible intrauterine device strings. Bimanual examination elicits significant cervical motion tenderness as well as bilateral adnexal fullness and guarding. A urine pregnancy test is negative. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Administer intramuscular ceftriaxone, oral doxycycline, and oral metronidazole; leave the intrauterine device in place

Answer

Administer intramuscular ceftriaxone, oral doxycycline, and oral metronidazole; leave the intrauterine device in place
The correct approach is to administer intramuscular ceftriaxone, oral doxycycline, and oral metronidazole while leaving the intrauterine device in place. This patient meets the clinical criteria for mild-to-moderate pelvic inflammatory disease (PID). Because she is hemodynamically stable, not pregnant, and lacks signs of severe systemic illness or a tubo-ovarian abscess, outpatient management is appropriate. The Centers for Disease Control and Prevention (CDC) recommends a single intramuscular dose of ceftriaxone along with 14 days of oral doxycycline and oral metronidazole to provide comprehensive coverage against Neisseria gonorrhoeae, Chlamydia trachomatis, and anaerobic organisms. Furthermore, current guidelines recommend leaving the intrauterine device in place during initial therapy; it should only be removed if the patient fails to show clinical improvement after 48 to 72 hours of targeted treatment.

Step-by-Step Solution

1
Identify the clinical syndrome based on the presentation.
The patient has pelvic pain, fever, mucopurulent cervicitis, and cervical motion tenderness, which establishes a clinical diagnosis of acute pelvic inflammatory disease (PID).
Recognizing the diagnostic criteria for PID is the first step before determining the setting of care and pharmacotherapy.
2
Determine the appropriate setting of care (inpatient vs. outpatient).
The patient is hemodynamically stable, tolerating oral intake, not pregnant, and lacks signs of a surgical emergency or severe systemic toxicity.
Mild-to-moderate PID can be safely managed in an outpatient setting, avoiding unnecessary hospitalization and intravenous antibiotics.
3
Select the guideline-concordant empiric antibiotic regimen.
Outpatient treatment requires coverage for N. gonorrhoeae, C. trachomatis, and anaerobes using a single dose of IM ceftriaxone plus 14 days of oral doxycycline and oral metronidazole.
Polymicrobial coverage is essential to prevent long-term sequelae such as infertility and chronic pelvic pain.
4
Address the presence of the copper intrauterine device (IUD).
The IUD should be left in place while initiating empiric antibiotics.
Evidence shows that early removal of an IUD does not improve clinical outcomes in acute PID. Removal is only indicated if there is no clinical improvement after 48-72 hours of appropriate antibiotic therapy.

Key Concept

Management of mild-to-moderate pelvic inflammatory disease in patients with an intrauterine device
Question 198Question →

A 32-year-old woman with poorly controlled type 2 diabetes mellitus comes to the clinic reporting severe vulvovaginal burning and irritation that has persisted for the past 3 weeks. She has been treated with two separate courses of oral fluconazole and a 7-day course of over-the-counter topical miconazole with no relief. Her last hemoglobin A1c was 8.7%. Pelvic examination reveals significant vulvovaginal erythema and edema with a few superficial excoriations. There is a moderate amount of thin, whitish vaginal discharge. The vaginal pH is 4.3. Microscopic evaluation of the discharge with saline and 10% potassium hydroxide (KOH) preparations reveals numerous inflammatory cells and small budding yeasts, but no pseudohyphae are identified. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Obtain a vaginal fungal culture and initiate treatment with intravaginal boric acid

Answer

The most appropriate next step is to obtain a vaginal fungal culture and initiate treatment with intravaginal boric acid.
The correct answer involves obtaining a fungal culture and initiating intravaginal boric acid. This patient's presentation of severe vulvovaginal burning, a normal vaginal pH (< 4.5), and a KOH prep showing budding yeast without pseudohyphae is classic for a non-albicans Candida infection, most commonly Candida glabrata. Poorly controlled diabetes mellitus is a significant risk factor for C. glabrata. Unlike Candida albicans, which forms both budding yeast and pseudohyphae, C. glabrata typically only forms spores (budding yeast). Furthermore, C. glabrata frequently exhibits intrinsic resistance to standard azole therapies (e.g., fluconazole, miconazole). When a patient fails standard azole therapy and lacks pseudohyphae on microscopy, a fungal culture is required for definitive speciation, and treatment should be transitioned to intravaginal boric acid capsules or topical flucytosine for 14 days.

Step-by-Step Solution

1
Analyze the clinical history and physical exam findings.
The patient is a diabetic woman with refractory vulvovaginal burning, severe erythema, and a normal vaginal pH (4.3).
Establishes that the underlying condition is most likely a yeast infection, as bacterial vaginosis and trichomoniasis typically present with an elevated vaginal pH > 4.5.
2
Interpret the microscopic evaluation (KOH prep).
Microscopy shows small budding yeasts but NO pseudohyphae.
Differentiates Candida albicans (which consistently forms both budding yeast and pseudohyphae) from non-albicans species like Candida glabrata (which only forms budding yeast/spores).
3
Synthesize the treatment failure and microscopic findings to select the appropriate pharmacotherapy.
Identify that the patient has an azole-resistant C. glabrata infection requiring fungal culture for speciation and intravaginal boric acid for effective treatment.
Standard azoles (fluconazole, miconazole) are highly ineffective against C. glabrata due to intrinsic resistance; boric acid or topical flucytosine are the recommended first-line alternatives.

Key Concept

Diagnosis and management of non-albicans vulvovaginal candidiasis (Candida glabrata)
Question 199Question →

Match each clinical presentation of a third-trimester hepatic or hypertensive complication with its corresponding underlying pathophysiologic mechanism.

Click a left item, then click its matching right item

Items

A 3434-year-old woman at 3636 weeks gestation presents with jaundice, vomiting, and altered mental status. Blood pressure is 130/85 mmHg130/85\text{ mmHg}. Labs demonstrate an AST of 250 U/L250\text{ U/L}, platelets of 90,000/μL90,000/\mu L, glucose of 40 mg/dL40\text{ mg/dL}, and a prolonged prothrombin time.
A 2828-year-old woman at 3535 weeks gestation presents with severe epigastric pain. Blood pressure is 165/105 mmHg165/105\text{ mmHg}. Labs show an AST of 350 U/L350\text{ U/L}, platelets of 60,000/μL60,000/\mu L, normal glucose, normal prothrombin time, and schistocytes on a peripheral blood smear.
A 3030-year-old woman at 3737 weeks gestation presents with new-onset dyspnea, orthopnea, and bibasilar crackles. Blood pressure is 170/110 mmHg170/110\text{ mmHg}. Labs show normal liver transaminases, a normal metabolic panel, and a platelet count of 120,000/μL120,000/\mu L.
A 3232-year-old woman at 3838 weeks gestation presents with intolerable nocturnal pruritus predominantly affecting her palms and soles. Blood pressure is 120/80 mmHg120/80\text{ mmHg}. Labs reveal normal hepatic transaminases, normal platelets, and significantly elevated total serum bile acids.

Matches

Show answer & explanation

Answer

The correct matching pairs clinical vignettes of severe obstetric complications to their distinct pathophysiologic mechanisms: the hypoglycemic and coagulopathic patient to microvesicular steatosis (AFLP), the patient with schistocytes and severe hypertension to microvascular endothelial damage (HELLP), the dyspneic patient with severe hypertension to increased capillary permeability (Preeclampsia with pulmonary edema), and the normotensive patient with pruritus to impaired biliary clearance (ICP).
The question requires differentiating the distinct pathophysiologic mechanisms of late-pregnancy hepatic and hypertensive complications based on targeted clinical and laboratory findings. AFLP is uniquely characterized by synthetic liver failure (hypoglycemia, coagulopathy). HELLP syndrome is driven by endothelial injury causing hemolysis and thrombocytopenia with preserved synthetic function. Severe preeclampsia can cause pulmonary edema via increased vascular permeability and afterload. ICP presents with isolated bile acid clearance issues without significant hypertension or hepatic necrosis.

Step-by-Step Solution

1
Analyze the first vignette for differentiating features of hepatic dysfunction in pregnancy.
Acute Fatty Liver of Pregnancy (AFLP) is identified.
The combination of profound hypoglycemia and coagulopathy (prolonged PT) points to synthetic liver failure, which differentiates AFLP from HELLP syndrome.
2
Evaluate the second vignette concerning severe epigastric pain, severe hypertension, and schistocytes.
HELLP syndrome is identified.
Schistocytes on a blood smear indicate microangiopathic hemolytic anemia. Combined with thrombocytopenia and preserved synthetic liver function, this confirms HELLP rather than AFLP.
3
Assess the third vignette detailing dyspnea, crackles, and severe hypertension.
Preeclampsia complicated by acute pulmonary edema is diagnosed.
The absence of liver enzyme elevation rules out HELLP/AFLP, while severe hypertension and respiratory compromise point to endothelial damage leading to capillary leak and alveolar transudation.
4
Interpret the fourth vignette featuring isolated palmar/plantar pruritus and elevated bile acids.
Intrahepatic Cholestasis of Pregnancy (ICP) is confirmed.
Normal blood pressure and isolated biliary clearance issues (elevated bile acids without hepatocellular necrosis) precisely describe ICP.

Key Concept

Differentiating third-trimester hepatic and hypertensive complications by their unique clinical and pathophysiologic signatures.
Question 200Question →

Match each intrapartum fetal heart rate pattern to its most likely underlying physiological etiology.

Click a left item, then click its matching right item

Items

Early deceleration
Late deceleration
Variable deceleration
Sinusoidal pattern

Matches

Show answer & explanation

Answer

Early deceleration corresponds to fetal head compression, late deceleration to uteroplacental insufficiency, variable deceleration to umbilical cord compression, and sinusoidal pattern to severe fetal anemia.
Each fetal heart rate pattern is tightly linked to a specific pathophysiological event. The 'VEAL CHOP' mnemonic correctly maps these relationships: Variable decelerations to Cord compression, Early decelerations to Head compression, Accelerations to Okay (normal oxygenation), and Late decelerations to Placental insufficiency. Additionally, a sinusoidal pattern uniquely indicates severe fetal anemia.

Step-by-Step Solution

1
Identify the underlying cause of early decelerations.
Early decelerations map to fetal head compression.
Head compression during a uterine contraction increases vagal tone, causing a benign, symmetric drop in fetal heart rate that mirrors the contraction.
2
Identify the underlying cause of late decelerations.
Late decelerations map to uteroplacental insufficiency.
Decreased oxygen delivery to the fetus during a contraction leads to a delayed heart rate drop that begins after the contraction peaks.
3
Identify the underlying cause of variable decelerations.
Variable decelerations map to umbilical cord compression.
Compression of the umbilical cord (e.g., from oligohydramnios or cord prolapse) causes an abrupt increase in fetal blood pressure, triggering a baroreceptor-mediated abrupt drop in heart rate.
4
Identify the underlying cause of a sinusoidal fetal heart rate pattern.
A sinusoidal pattern maps to severe fetal anemia.
Severe hypoxia or anemia (e.g., from vasa previa, alloimmunization) abolishes normal autonomic control, resulting in a smooth, undulating baseline.

Key Concept

Fetal heart rate monitoring patterns and their underlying etiologies
Estimated Time:45s
PreviousPage 10 / 53Next
Obstetrics and Gynecology Practice Questions — USMLE Step 2 CK — Page 10 | Examkin